FDA Moves to Close Loophole
Back in 2011, the Pliva v. Mensing ruling from the Supreme Court of the United States revealed a loophole in federal regulation of generic drugs. Generic drug manufacturers were not responsible for the updating of labels; it was left to brand name companies. In the past two years, the Food and Drug Administration (FDA) has moved towards closing this regulation loophole. After a public comment period, requirements are expected to change and these generic drug…